Organized by the Department of Biotechnology, the Ministry of Science & Technology, the Government of India and it’s Public Sector Undertaking, Biotechnology Industry Research Assistance Council, Global Bio-India 2021 aims to showcase opportunities in Indian Biotechnology sector to the world.
Session
Strategic partnership for medical innovation in India: Addressing critical treatment gaps for neglected tropical diseases and drug-resistant bacterial infections
Date: Wednesday, 3 March 2021
Time: 14:30-15:30
| Opening address, DBT’s Vision for innovation in infectious diseases post Covid-19 and announcement of MoU of DBT through BIRAC with DNDi & GARDP Dr Renu Swarup Secretary Department of Biotechnology, Govt of India |
| AMR pathogen priority list and WHO’s vision for AMR and neglected diseases Dr Roderico H. Ofrin, WHO Representative in India |
| DNDi’s alternative innovation model and end-to-end approach for R&D in India Dr Bernard Pecoul, Executive Director, DNDi |
| GARDP’s vision: From discovery to access in India and beyond Dr Manica Balasegaram, Executive Director, GARDP |
| Role of Industry for innovation in India Pankaj Patel, Chairman, Zydus Cadila |
Panel discussion: ‘Fostering Innovation and R&D to address infectious diseases in India and beyond’
Moderator: Dr Harish Iyer, BMGF
Seakers:
- Dr VG Somani, DCGI, CDSCO
- Leena Menghaney, MSF Access Campaign
- Charles Mowbray, Discovery Director, DNDi
- Dr Seamus O’ Brien, GARDP
- Dr S Mukherjee, BIRAC
- Anand Anandkumar, Bugworks
- Dr Thomas Van Boeckel, ETH Zürich
| Closing remarks Dr Sundeep Sarin, Department of Biotechnology, Govt of India |
